Defective DNA endonuclease activity on anthramycin treated DNA in xeroderma pigmentosum and mouse melanoma cells.
D000818:Animals; D000876:Anthramycin / Q000494:pharmacology*; D001570:Benzodiazepinones / Q000494:pharmacology*; D002460:Cell Line; D002843:Chromatin / Q000201:enzymology; D004273:DNA, Neoplasm / Q000378:metabolism; D004279:DNA, Viral; D003850:Deoxyribonuclease I; D004706:Endodeoxyribonucleases / Q000302:isolation & purification / Q000378:metabolism*; D006801:Humans; D008214:Lymphocytes / Q000201:enzymology; D008545:Melanoma / Q000201:enzymology*; D051379:Mice; D009374:Neoplasms, Experimental / Q000201:enzymology; D014983:Xeroderma Pigmentosum / Q000201:enzymology*
D001570:Benzodiazepinones; D002843:Chromatin; D004273:DNA, Neoplasm; D004279:DNA, Viral; D000876:Anthramycin; D004706:Endodeoxyribonucleases; D003850:Deoxyribonuclease I